That’s grand.
Tennis great Chris Evert said Monday she’d completed chemotherapy to treat stage 1 ovarian cancer.
“I’m a little out of it (meds) but nonetheless, thankful and relieved I finished my six chemo treatments,” Evert, 67, posted on Twitter along with a video thanking health care workers.
Evert who won 18 Grand Slam titles and was the year-end number one seven times during her career announced in January 2022 that she had been diagnosed with ovarian cancer and wanted to share her experience “and the story behind it as a way to help others.”
Evert previously said she was told by doctors her cancer was detected early so it was 90% likely it would not return.
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/tronc/MQQVERKGJBAZBN7RI6M6VBNSA4.jpg)
Evert’s sister, former pro tennis player Jeanne Evert Dubin, died from ovarian cancer in 2020 at the age of 62. Dubin’s cancer had spread beyond viability for treatment by the time it was detected.
Almost 20,000 women are diagnosed with ovarian cancer every year, according to the American Cancer Society. However, it accounts for the fifth-most of all cancer deaths for women. A woman’s odds of getting ovarian cancer during their life are about 1 in 78. It primarily afflicts older women with more than half of those diagnosed over the age of 63, though diagnoses have overall been falling over the last 20 years.
